CS Diagnostics Corp. (CSDX)

CS Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2009	FY 2008	FY 2007
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Cash & Equivalents	0.05	0	0.02	0.04	0.04	0.04
Cash & Short-Term Investments	0.05	0	0.02	0.04	0.04	0.04
Cash Growth	37.48%	-97.54%	-45.52%	-0.01%	-0.27%	3288.97%
Total Current Assets	0.11	0	0.02	0.04	0.04	0.04
Property, Plant & Equipment	-	-	-	0.02	0.02	0
Other Intangible Assets	499.4	499.4	499.4	-	-	-
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	499.51	499.4	499.42	0.06	0.06	0.04
Accounts Payable	0	0	0.01	1.15	0.85	0.79
Accrued Expenses	-	-	-	0.72	0.75	0.77
Short-Term Debt	-	-	-	-	-	0.37
Current Income Taxes Payable	-	-	-	-	-	0
Total Current Liabilities	0	0	0.01	1.87	1.6	1.93
Long-Term Debt	-	-	-	-	-	1.03
Other Long-Term Liabilities	0.07	-	-	-	-	-
Total Liabilities	0.07	0	0.01	1.87	1.6	2.96
Common Stock	0	0	0	0.05	0.05	0.03
Additional Paid-In Capital	504.16	504.16	504.17	4.13	4.13	2.36
Retained Earnings	-4.74	-4.77	-4.77	-5.99	-5.72	-5.32
Comprehensive Income & Other	-	-0	-	-	-	-
Total Common Equity	499.43	499.4	499.41	-1.81	-1.54	-2.92
Shareholders' Equity	499.43	499.4	499.41	-1.81	-1.54	-2.92
Total Liabilities & Equity	499.51	499.4	499.42	0.06	0.06	0.04
Total Debt	-	-	-	-	-	1.39
Net Cash (Debt)	0.05	0	0.02	0.04	0.04	-1.36
Net Cash Growth	37.48%	-97.54%	-45.52%	-0.01%	-	-
Net Cash Per Share	0.00	-	0.00	0.39	0.39	-
Filing Date Shares Outstanding	137.34	137.34	110.79	0.1	0.1	-
Total Common Shares Outstanding	137.34	137.29	110.79	0.1	0.1	-
Working Capital	0.1	-0	0.01	-1.84	-1.57	-1.9
Book Value Per Share	3.64	3.64	4.51	-18.79	-15.99	-
Tangible Book Value	0.03	-0	0.01	-1.81	-1.54	-2.92
Tangible Book Value Per Share	0.00	-0.00	0.00	-18.79	-15.99	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.